PURA VIDA INVESTMENTS, LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$612,000
-26.6%
89,886
-21.4%
0.02%
-12.0%
Q3 2021$834,000
-41.8%
114,343
-20.1%
0.02%
-44.4%
Q2 2021$1,434,000
-36.5%
143,120
-39.4%
0.04%
-29.7%
Q1 2021$2,257,000
+70.9%
236,311
+58.7%
0.06%
-5.9%
Q3 2020$1,321,000148,9490.07%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,567,985$8,491,8042.58%
Aisling Capital Management LP 1,043,267$2,482,9751.02%
Atom Investors LP 156,168$371,6800.08%
Pentwater Capital Management LP 5,975,000$14,220,5000.08%
CORNERCAP INVESTMENT COUNSEL INC 79,709$189,7070.04%
Forefront Analytics, LLC 24,969$59,4280.03%
Callan Capital, LLC 76,559$182,2100.02%
XTX Topco Ltd 40,782$97,0610.02%
Advisory Services Network, LLC 257,271$612,3050.02%
RBF Capital, LLC 70,171$167,0070.01%
View complete list of POSEIDA THERAPEUTICS INC shareholders